News and Events

Dr. Jessica Hochberg to speak at the fourth International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma on June 27th. Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma. https://www.iscayahl.com/